^
Association details:
Biomarker:AEBP1 overexpression
Cancer:Glioma
Drug:temozolomide (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
Title:

Molecular Characterization of AEBP1 at Transcriptional Level in Glioma

Published date:
07/31/2021
Excerpt:
AEBP1 was overexpressed in GSCs and TMZ resistance cells...The survival analysis showed that the overexpressed level of AEBP1 was correlated with short survival time in both glioma and GBM patients.
DOI:
10.1155/2021/5579359